| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 16.99B | — |
| Operating expense | — | — |
| Net income | 3.61B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 4AB.F returned +31.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +19.5% |
| 1 year | +31.3% |
| 5 years | +171.6% |
| 10 years | +531.9% |
| All-time high | €227.50 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 4AB.F would be worth today ›Yes. AbbVie Inc. paid 4 dividends over the past 12 months. The most recent was €1.48 per share on Jul 15, 2026. The dividend yield is 2.64%.
AbbVie Inc. is part of the Healthcare sector.
AbbVie Inc. has a market cap of 402.02B EUR, based on the latest quote.
AbbVie Inc. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
